La Jolla Pharma Company Profile
✉ Email this page to a colleague
What is the competitive landscape for LA JOLLA PHARMA, and when can generic versions of LA JOLLA PHARMA drugs launch?
LA JOLLA PHARMA has one approved drug.
There are ten US patents protecting LA JOLLA PHARMA drugs.
There are thirty-two patent family members on LA JOLLA PHARMA drugs in twenty-one countries.
Summary for La Jolla Pharma
International Patents: | 32 |
US Patents: | 10 |
Tradenames: | 1 |
Ingredients: | 1 |
NDAs: | 1 |
Drugs and US Patents for La Jolla Pharma
International Patents for La Jolla Pharma Drugs
Country | Patent Number | Estimated Expiration |
---|---|---|
South Korea | 20160117437 | See Plans and Pricing |
European Patent Office | 3607962 | See Plans and Pricing |
Japan | 6824739 | See Plans and Pricing |
Hungary | E047062 | See Plans and Pricing |
Serbia | 59804 | See Plans and Pricing |
World Intellectual Property Organization (WIPO) | 2017120438 | See Plans and Pricing |
>Country | >Patent Number | >Estimated Expiration |
Similar Applicant Names
Here is a list of applicants with similar names.